Topical Ketorolac Pretreatment for Successful Prevention of Recurrent Transcranial Direct Current Stimulation-Associated Skin Erythema

Swarndeep Singh, Shivram, Pankaj Verma

Open source

DOI
10.1097/yct.0000000000001330
Published
2026-09-22
Container
The Journal of ECT
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/yct.0000000000001330,
  title = {Topical Ketorolac Pretreatment for Successful Prevention of Recurrent Transcranial Direct Current Stimulation-Associated Skin Erythema},
  author = {Swarndeep Singh and Shivram and Pankaj Verma},
  year = {2026},
  journal = {The Journal of ECT},
  doi = {10.1097/yct.0000000000001330},
  url = {https://doi.org/10.1097/yct.0000000000001330}
}

RIS

TY  - JOUR
TI  - Topical Ketorolac Pretreatment for Successful Prevention of Recurrent Transcranial Direct Current Stimulation-Associated Skin Erythema
AU  - Swarndeep Singh
AU  - Shivram
AU  - Pankaj Verma
PY  - 2026
JO  - The Journal of ECT
DO  - 10.1097/yct.0000000000001330
UR  - https://doi.org/10.1097/yct.0000000000001330
ER  - 

APA

Singh, S., Shivram, & Verma, P. (2026). Topical Ketorolac Pretreatment for Successful Prevention of Recurrent Transcranial Direct Current Stimulation-Associated Skin Erythema. The Journal of ECT. https://doi.org/10.1097/yct.0000000000001330

Source records